trending Market Intelligence /marketintelligence/en/news-insights/trending/c5qk9d_p-fyeatsu6o3m6w2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Ampio Pharmaceuticals plans common stock, warrants offering


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

Ampio Pharmaceuticals plans common stock, warrants offering

Englewood, Colo.-based Ampio Pharmaceuticals Inc. plans to sell its common shares and accompanying warrants to buy common shares in an underwritten public offering.

The clinical trial stage biopharmaceutical company will sell all of the securities in the proposed offering.

Net proceeds from the offering will be used for working capital and general corporate purposes, including continued preclinical development of Ampion and funding an Ampion clinical trial, if required.

Canaccord Genuity is acting as sole book-running manager for the proposed offering.